Status
Conditions
Treatments
About
The purpose of this research study is to evaluate adult children of parents with and without Alzheimer's disease which represent an ideal population for investigating the biological changes that precede the clinical onset of AD. The investigators will be imaging the brain to detect the presence of amyloid deposits (plaques in the brain). Amyloid is a protein that may be related to dementia of Alzheimer's disease (DAT).
Full description
This study will use a radioactive tracer called [11C]-Pittsburgh Compound B (11C]PIB), which is a tracer that binds to beta amyloid protein in the brain. This compound is considered investigational, which means that it has not been approved by the United States Food and Drug Administration (FDA).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
375 participants in 1 patient group
Loading...
Central trial contact
Kelley Jackson
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal